Hi Red Adair, assuming WKT complete Lindi within 12 months what is your forecast for the following?
1) Approximate date when Lindi becomes a cash flow positive operation,
2) The number of issued shares in WKT at the time when it achieves positive cash flow.
It is apparent that all the holders here with a "Buy" sentiment think that completion of the Jinpeng EPC contract will result in a much higher share price. Contrary to that bullish attitude, professional investors are asking themselves the two questions above and electing to stay on the sidelines.
It is admirable for you to stay loyal to the company, its directors and your fellow shareholders but if you can't afford to risk your capital with impunity then you owe it to yourself to answer the above. Nobody has a crystal ball on graphite prices or indeed the extent to which Lindi will perform in comparison with the DFS metrics, however blindly assuming all will be fine once the plant EPC contract is complete is ill advised.
- Forums
- ASX - By Stock
- WKT
- Ann: Construction supported by bridging loan
Ann: Construction supported by bridging loan, page-88
-
-
- There are more pages in this discussion • 150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WKT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $65.78M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.8¢ | $7.077K | 72.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28040 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 78310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28040 | 0.098 |
2 | 366905 | 0.097 |
3 | 73820 | 0.096 |
4 | 142895 | 0.095 |
1 | 100000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 78310 | 1 |
0.110 | 1331213 | 8 |
0.115 | 353198 | 6 |
0.120 | 477177 | 4 |
0.125 | 219579 | 4 |
Last trade - 15.51pm 10/10/2024 (20 minute delay) ? |
Featured News
WKT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online